P&T
Our
Other
Journal
MediMedia Managed Markets
Managed Care

 

Transforming Dyslipidemia Management

Transforming Dyslipidemia Management

This supplement derives from the 2002 Medical Director Colloquy, a forum for interaction between decision makers in managed care and professionals from academic health centers, quality assurance organizations, and the business world. Lipid management involves numerous critical issues, including efficacy and treatment choices. In addition, successful lipid management brings an economic challenge, because it involves a long-term approach to improving care — with results that may not be immediately apparent. This publication, the first of two based on presentations at the 2002 colloquy, places these issues in perspective for medical and pharmacy directors. Additional presentations and continuing education opportunities are available through "Multidisciplinary Management of Dyslipidemia," the second Managed Care supplement from this meeting.

Highlights:

  • Current Drug Treatments for Lipid Management
  • Promising Therapies for Cholesterol Reduction
  • The Life Science Revolution
  • NCQA's Evolving Clinical Performance Measures
  • Innovation in Disease Management